NCT00245063View on ClinicalTrials.gov

AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Recurrent Non-small Cell Lung Cancer
Interventions
DRUG

cediranib maleate

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacogenomic studies

Optional correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00245063 - AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter